NCT01351805 2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA Completed
Clinical Trials
9 trialsNCT02101970 2022-01-24
Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women
University of Kansas Medical Center
Phase NA Completed
NCT01661764 2018-06-08
Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention
Vanderbilt University Medical Center
Phase 2 Completed
NCT00815685 2017-03-23
A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT00031707 2016-07-14
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT02069561 2015-09-18
EPAUC
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase NA Completed
NCT00510692 2014-08-22
Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA
S.L.A. Pharma AG
Phase 2/3 Completed
NCT00432913 2008-10-17
Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa
S.L.A. Pharma AG
Phase 2/3 Completed
NCT00168987 2008-05-09
Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors
Charite University, Berlin, Germany
Phase 4 Completed